Yang Liu - Publications

Affiliations: 
University of Michigan-Ann Arbor 

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W, Liu Y, Wang Y, Liu X, Chan MWY, Liu JQ, Love R, Liu CG, Godfrey V, Shen R, ... ... Liu Y, et al. FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene. Cell. 184: 6378. PMID 34942100 DOI: 10.1016/j.cell.2021.11.030  0.445
2021 Liu Y, Chen W, Yu M, Li H, Cheng H, Cao J, Yan Z, Shi M, Zhu F, Sun H, Sang W, Li D, Wu Q, Chen C, Zheng J, et al. Absolute lymphocyte count prior lymphodepletion impacts outcomes in multiple myeloma patients treated with CAR-T cells. Transplantation and Cellular Therapy. PMID 34861455 DOI: 10.1016/j.jtct.2021.11.016  0.374
2021 Zhu JY, Huang X, Fu Y, Wang Y, Zheng P, Liu Y, Han Z. Pharmacological or genetic inhibition of hypoxia signaling attenuates oncogenic RAS-induced cancer phenotypes. Disease Models & Mechanisms. PMID 34580712 DOI: 10.1242/dmm.048953  0.478
2021 Peng G, Wang Y, Ge P, Bailey C, Zhang P, Zhang D, Meng Z, Qi C, Chen Q, Chen J, Niu J, Zheng P, Liu Y, Liu Y. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin. Journal of Experimental & Clinical Cancer Research : Cr. 40: 278. PMID 34470658 DOI: 10.1186/s13046-021-02082-7  0.474
2021 Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, ... ... Liu Y, et al. Immunological Insights Into the Therapeutic Roles of CD24Fc Against Severe COVID-19. Medrxiv : the Preprint Server For Health Sciences. PMID 34462760 DOI: 10.1101/2021.08.18.21262258  0.476
2021 Liu Y, Nelson MV, Bailey C, Zhang P, Zheng P, Dome JS, Liu Y, Wang Y. Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor. Oncogene. PMID 34155347 DOI: 10.1038/s41388-021-01907-1  0.606
2021 Huang X, Liu Y, Wang Y, Bailey C, Zheng P, Liu Y. Dual Targeting Oncoproteins MYC and HIF1α Regresses Tumor Growth of Lung Cancer and Lymphoma. Cancers. 13. PMID 33572152 DOI: 10.3390/cancers13040694  0.634
2020 Gao H, Cai H, Liu J, Wang X, Zheng P, Devenport M, Xu T, Dou F, Liu Y, Zhou A. Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody. Cell Discovery. 6: 79. PMID 33298884 DOI: 10.1038/s41421-020-00202-9  0.586
2020 Zhang P, Liu M, Cui Y, Zheng P, Liu Y. Microsatellite instability status differentially associates with intratumoral immune microenvironment in human cancers. Briefings in Bioinformatics. PMID 32823273 DOI: 10.1093/bib/bbaa180  0.625
2020 Bailey CM, Liu Y, Peng G, Zhang H, He M, Sun D, Zheng P, Liu Y, Wang Y. Liposomal formulation of HIF-1α inhibitor Echinomycin eliminates established metastases of triple-negative breast Cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. 102278. PMID 32738299 DOI: 10.1016/J.Nano.2020.102278  0.605
2020 Tian RR, Zhang MX, Liu M, Fang X, Li D, Zhang L, Zheng P, Zheng YT, Liu Y. CD24Fc protects against viral pneumonia in simian immunodeficiency virus-infected Chinese rhesus monkeys. Cellular & Molecular Immunology. PMID 32382131 DOI: 10.1038/s41423-020-0452-5  0.548
2020 Wang Y, Liu Y, Bailey C, Zhang H, He M, Sun D, Zhang P, Parkin B, Baer MR, Zheng P, Malek SN, Liu Y. Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin. Oncogene. PMID 32060420 DOI: 10.1038/S41388-020-1201-Z  0.616
2020 Zhang P, Xiong X, Rolfo C, Du X, Zhang Y, Yang H, Russo A, Devenport M, Zhou P, Liu Y, Zheng P. Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies. Cancers. 12. PMID 31991588 DOI: 10.3390/Cancers12020284  0.648
2019 Liu Y, Zheng P. Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy. Trends in Pharmacological Sciences. PMID 31836191 DOI: 10.1016/j.tips.2019.11.003  0.66
2019 Paluskievicz CM, Cao X, Abdi R, Zheng P, Liu Y, Bromberg JS. T Regulatory Cells and Priming the Suppressive Tumor Microenvironment. Frontiers in Immunology. 10: 2453. PMID 31681327 DOI: 10.3389/fimmu.2019.02453  0.646
2019 Zhang P, Chou HY, Young L, Zheng P, Liu Y. En masse discovery of anti-cancer human monoclonal antibodies by de novo assembly of immunoglobulin sequences from transcriptomes and genome sequences of cancer tissues. Cellular & Molecular Immunology. PMID 31562388 DOI: 10.1038/s41423-019-0299-9  0.595
2019 Chen C, Li F, Ma MM, Zhang S, Liu Y, Yan ZL, Chen W, Cao J, Zeng LY, Wang XY, Xu KL, Wu QY. Roles of T875N somatic mutation in the activity, structural stability of JAK2 and the transformation of OCI-AML3 cells. International Journal of Biological Macromolecules. PMID 31299252 DOI: 10.1016/j.ijbiomac.2019.07.065  0.49
2019 Zhang Y, Du X, Liu M, Tang F, Zhang P, Ai C, Fields JK, Sundberg EJ, Latinovic OS, Devenport M, Zheng P, Liu Y. Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy. Cell Research. PMID 31267017 DOI: 10.1038/s41422-019-0184-1  0.637
2019 Zhang P, Zheng P, Liu Y. Amplification of the Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer. Frontiers in Genetics. 10: 560. PMID 31244889 DOI: 10.3389/fgene.2019.00560  0.609
2019 Tao R, Murad N, Xu Z, Zhang P, Okonechnikov K, Kool M, Rivero-Hinojosa S, Lazarski C, Zheng P, Liu Y, Eberhart CG, Rood BR, Packer R, Pei Y. MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. Cancer Research. PMID 30862721 DOI: 10.1158/0008-5472.Can-18-1787  0.627
2018 Liu Y, Zheng P. How Does an Anti-CTLA-4 Antibody Promote Cancer Immunity? Trends in Immunology. 39: 953-956. PMID 30497614 DOI: 10.1016/j.it.2018.10.009  0.631
2018 Tian RR, Zhang MX, Zhang LT, Zhang P, Ma JP, Liu M, Devenport M, Zheng P, Zhang XL, Lian XD, Ye M, Zheng HY, Pang W, Zhang GH, Zhang LG, ... Liu Y, et al. CD24 and Fc fusion protein protects SIVmac239-infected Chinese rhesus macaque against progression to AIDS. Antiviral Research. 157: 9-17. PMID 29983395 DOI: 10.1016/j.antiviral.2018.07.004  0.624
2018 Tang F, Du X, Liu M, Zheng P, Liu Y. Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade? Cell & Bioscience. 8: 30. PMID 29713453 DOI: 10.1186/s13578-018-0229-z  0.649
2018 Zhu J, Liu JQ, Shi M, Cheng X, Ding M, Zhang JC, Davis JP, Varikuti S, Satoskar AR, Lu L, Pan X, Zheng P, Liu Y, Bai XF. IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy. Jci Insight. 3. PMID 29618655 DOI: 10.1172/Jci.Insight.98745  0.601
2018 Flores R, Zhang P, Wu W, Wang X, Ye P, Zheng P, Liu Y. Siglec genes confer resistance to systemic lupus erythematosus in humans and mice. Cellular & Molecular Immunology. PMID 29503442 DOI: 10.1038/cmi.2017.160  0.609
2018 Du X, Tang F, Liu M, Su J, Zhang Y, Wu W, Devenport M, Lazarski CA, Zhang P, Wang X, Ye P, Wang C, Hwang E, Zhu T, Xu T, ... ... Liu Y, et al. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. Cell Research. PMID 29472691 DOI: 10.1038/s41422-018-0011-0  0.661
2018 Du X, Liu M, Su J, Zhang P, Tang F, Ye P, Devenport M, Wang X, Zhang Y, Liu Y, Zheng P. Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice. Cell Research. PMID 29463898 DOI: 10.1038/s41422-018-0012-z  0.665
2018 Li D, Hu M, Liu Y, Ye P, Du P, Li CS, Cheng L, Liu P, Jiang J, Su L, Wang S, Zheng P, Liu Y. CD24-p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages. Cell Discovery. 4: 6. PMID 29423273 DOI: 10.1038/S41421-017-0007-9  0.597
2017 Tanno T, Zhang P, Lazarski CA, Liu Y, Zheng P. An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth. Blood Advances. 1: 1107-1119. PMID 29296753 DOI: 10.1182/bloodadvances.2017004705  0.599
2017 Tang F, Zhang P, Ye P, Lazarski CA, Wu Q, Bergin IL, Bender TP, Hall MN, Cui Y, Zhang L, Jiang T, Liu Y, Zheng P. A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice. Elife. 6. PMID 29206103 DOI: 10.7554/Elife.32497  0.637
2017 Zhang P, Wu X, Basu M, Dong C, Zheng P, Liu Y, Sandler AD. MYCN Amplification Is Associated with Repressed Cellular Immunity in Neuroblastoma: An In Silico Immunological Analysis of TARGET Database. Frontiers in Immunology. 8: 1473. PMID 29163537 DOI: 10.3389/fimmu.2017.01473  0.613
2017 Li N, Zheng P, Liu Y. The CD24-Siglec G axis protects mice against cuprizone-induced oligodendrocyte loss: targeting danger signal for neuroprotection. Cellular & Molecular Immunology. PMID 28757612 DOI: 10.1038/cmi.2017.47  0.604
2017 Toubai T, Rossi C, Oravecz-Wilson K, Zajac C, Liu C, Braun T, Fujiwara H, Wu J, Sun Y, Brabbs S, Tamaki H, Magenau J, Zheng P, Liu Y, Reddy P. Siglec-G represses DAMP-mediated effects on T cells. Jci Insight. 2. PMID 28724800 DOI: 10.1172/jci.insight.92293  0.518
2016 Liu Y, Wang Y, Du Z, Yan X, Zheng P, Liu Y. Fbxo30 Regulates Mammopoiesis by Targeting the Bipolar Mitotic Kinesin Eg5. Cell Reports. PMID 27117404 DOI: 10.1016/j.celrep.2016.03.083  0.616
2016 Li CS, Tang F, Zhang P, Jiang T, Saunders TL, Zheng P, Liu Y. Trap1a is an X-linked and cell-intrinsic regulator of thymocyte development. Cellular & Molecular Immunology. PMID 27063468 DOI: 10.1038/cmi.2015.108  0.646
2015 Xu X, Li L, Wang C, Liu Y, Chen C, Yan J, Ding H, Tang SY. The expansion of autologous adipose-derived stem cells in vitro for the functional reconstruction of nasal mucosal tissue. Cell & Bioscience. 5: 54. PMID 26388989 DOI: 10.1186/s13578-015-0045-7  0.354
2015 Li F, Li W, Liu Y, Tong YX, Zhou P, Wang L, Chen C, Zeng LY, Wu QY, Wang XY, Xu KL. Effects of the I682F mutation on JAK2's activity, structure and stability. International Journal of Biological Macromolecules. 79: 118-125. PMID 25940527 DOI: 10.1016/j.ijbiomac.2015.04.063  0.359
2015 Liu R, Liu C, Chen D, Yang WH, Liu X, Liu CG, Dugas CM, Tang F, Zheng P, Liu Y, Wang L. FOXP3 Controls an miR-146/NF-κB Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells. Cancer Research. 75: 1703-13. PMID 25712342 DOI: 10.1158/0008-5472.CAN-14-2108  0.612
2015 Ye P, Liu Y, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular Cell. 57: 708-20. PMID 25639470 DOI: 10.1016/j.molcel.2014.12.034  0.667
2015 Chen Z, Shen H, Sun C, Yin L, Tang F, Zheng P, Liu Y, Brink R, Rui L. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. American Journal of Physiology. Endocrinology and Metabolism. 308: E460-9. PMID 25628422 DOI: 10.1152/ajpendo.00470.2014  0.586
2015 Wang L, Liu R, Ye P, Wong C, Chen GY, Zhou P, Sakabe K, Zheng X, Wu W, Zhang P, Jiang T, Bassetti MF, Jube S, Sun Y, Zhang Y, ... ... Liu Y, et al. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nature Communications. 6: 5909. PMID 25600590 DOI: 10.1038/Ncomms6909  0.621
2015 Wong C, Chen C, Wu Q, Liu Y, Zheng P. A critical role for the regulated wnt-myc pathway in naive T cell survival. Journal of Immunology (Baltimore, Md. : 1950). 194: 158-67. PMID 25429066 DOI: 10.4049/jimmunol.1401238  0.699
2014 Chen GY, Brown NK, Wu W, Khedri Z, Yu H, Chen X, van de Vlekkert D, D'Azzo A, Zheng P, Liu Y. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. Elife. 3: e04066. PMID 25187624 DOI: 10.7554/Elife.04066  0.595
2014 Xiong X, Zhao Y, Tang F, Wei D, Thomas D, Wang X, Liu Y, Zheng P, Sun Y. Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis. Elife. 3: e02236. PMID 25144937 DOI: 10.7554/eLife.02236  0.59
2014 Chen GY, Brown NK, Zheng P, Liu Y. Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity. Glycobiology. 24: 800-6. PMID 24996822 DOI: 10.1093/glycob/cwu068  0.641
2014 Wang Y, Liu Y, Tang F, Bernot KM, Schore R, Marcucci G, Caligiuri MA, Zheng P, Liu Y. Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells. Blood. 124: 1127-35. PMID 24994068 DOI: 10.1182/Blood-2013-12-544221  0.617
2014 Thaxton JE, Liu B, Zheng P, Liu Y, Li Z. Deletion of CD24 impairs development of heat shock protein gp96-driven autoimmune disease through expansion of myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 192: 5679-86. PMID 24808359 DOI: 10.4049/jimmunol.1302755  0.639
2014 Toubai T, Hou G, Mathewson N, Liu C, Wang Y, Oravecz-Wilson K, Cummings E, Rossi C, Evers R, Sun Y, Wu J, Choi SW, Fang D, Zheng P, Liu Y, et al. Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice. Blood. 123: 3512-23. PMID 24695850 DOI: 10.1182/blood-2013-12-545335  0.629
2014 Geng HL, Bian MR, Liu Y, Cao J, Chen C, Wang ZY, Li ZY, Zeng LY, Wang XY, Wu QY, Xu KL. The D14 and R138 ion pair is involved in dimeric arginine kinase activity, structural stability and folding. International Journal of Biological Macromolecules. 66: 302-10. PMID 24582938 DOI: 10.1016/j.ijbiomac.2014.02.039  0.317
Show low-probability matches.